Benzinga - Fri, 19 Mar 2021 04:42:22 -0400
Benzinga - Thu, 18 Mar 2021 12:23:09 -0400
Benzinga - Thu, 18 Mar 2021 07:01:02 -0400
Benzinga - Wed, 17 Mar 2021 16:20:27 -0400
Benzinga - Wed, 17 Mar 2021 05:12:26 -0400
Benzinga - Tue, 16 Mar 2021 12:40:54 -0400
Benzinga - Tue, 16 Mar 2021 12:06:53 -0400
Benzinga - Tue, 16 Mar 2021 10:38:11 -0400
Benzinga - Tue, 16 Mar 2021 10:36:43 -0400
load more
Sector: Health Care.Industry: Biotechnology
Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices. In the assistive device program, the company focuses on producing a wearable assistive device for patients with DMD.

Earnings

see more
Q4 2020Est.ActualSurprise
EPS-0.310
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SLDBSolid Biosciences-2.51%555.1M

Solid Biosciences Company Questions & Answers

Q

How do I buy Solid Biosciences (SLDB) stock?

A

You can purchase shares of Solid Biosciences (NASDAQ: SLDB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Solid Biosciences's (SLDB) main competitors?

A

Other companies in Solid Biosciences’s space includes: 89bio (NASDAQ:ETNB), Chinook Therapeutics (NASDAQ:KDNY) and Eagle Pharmaceuticals (NASDAQ:EGRX).

Q

What is the target price for Solid Biosciences?

A

The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by Chardan Capital on 2021-03-16. The analyst firm set a price target for 20.00 expecting SLDB to rise to within 12 months (a possible 296.83% upside). 7 analyst firms have reported ratings in the last year.

Q

How much is Solid Biosciences (SLDB) stock ?

A

The stock price for Solid Biosciences (NASDAQ: SLDB) is $5.04 last updated Fri Apr 16 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Solid Biosciences (SLDB) dividend?

A

There are no upcoming dividends for Solid Biosciences.

Q

When is Solid Biosciences (NASDAQ:SLDB) reporting earnings?

A
Solid Biosciences’s Q4 earnings are confirmed from now on March 15, 2021.
Q

When is the upcoming split for SLDB?

A

There is no upcoming split for Solid Biosciences.